International Journal of Clinical Oncology and Cancer Research

Volume 2, Issue 6, December 2017

  • BRAFV600E Mutation in Gliomas in Iraqi Patients Immunohistochemical Study

    Zahraa Marwan Shaban, Salim Rashid Al-Aubaidy

    Issue: Volume 2, Issue 6, December 2017
    Pages: 123-128
    Received: 11 October 2017
    Accepted: 27 October 2017
    Published: 3 December 2017
    DOI: 10.11648/j.ijcocr.20170206.11
    Abstract: Gliomas considered the most common primary malignant brain tumors in adults. BRAFV600E mutation occurs more in pediatric gliomas but less frequent in adult gliomas. This study aims to assess the frequency of BRAF mutation in Iraqi patients with gliomas by immunohistochemical study and to correlate its immunoreactivity with some clinicopathological ... Show More
  • Testing Treatment Effect in Randomized Clinical Trials with Possible Non-proportional Hazards

    Belay Belete Anjullo, Roel Braekers

    Issue: Volume 2, Issue 6, December 2017
    Pages: 129-140
    Received: 23 July 2017
    Accepted: 26 October 2017
    Published: 8 December 2017
    DOI: 10.11648/j.ijcocr.20170206.12
    Abstract: Many randomized clinical trials include right censored time to event data, comparing an experimental treatment with a standard treatment or placebo control. In this comparison, one tests whether the two treatments have the same survival function or equivalently the same hazard function over a given time period in order to evaluate effect of treatme... Show More
  • Breast Cancer: Clinical and Pathological Study at Lubumbashi and Kinshasa University Hospitals in the Democratic Republic of the Congo from 2014 to 2015

    Nday Guy, Kabamba Michel, Mukalay Abdon, Tshilombo François, Odimba Etienne, Lebwaz Bienvenu, Kalenga Prospère, Ilunga Julien

    Issue: Volume 2, Issue 6, December 2017
    Pages: 141-148
    Received: 27 August 2017
    Accepted: 21 September 2017
    Published: 3 January 2018
    DOI: 10.11648/j.ijcocr.20170206.13
    Abstract: Often tumors in the African setting are described aggressive with high grading status. There is no national cancer registry nor suitable data on breast cancer in DRC. Better knowledge of this entity can improve its management. To demonstrate the clinical and pathological profile of breast cancer in Kinshasa and Lubumbashi (DR Congo). Cross-sectiona... Show More